Application 017106
- Type
- NDA
- Sponsor
- MERIDIAN MEDCL TECHN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATROPEN | ATROPINE | SOLUTION;INTRAMUSCULAR | EQ 2MG SULFATE/0.7ML | Yes | Yes |
| 002 | ATROPEN | ATROPINE | SOLUTION;INTRAMUSCULAR | EQ 1MG SULFATE/0.7ML | Yes | Yes |
| 003 | ATROPEN | ATROPINE | SOLUTION;INTRAMUSCULAR | EQ 0.5MG SULFATE/0.7ML | Yes | Yes |
| 004 | ATROPEN | ATROPINE | SOLUTION;INTRAMUSCULAR | EQ 0.25MG SULFATE/0.3ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N017106-001 | ATROPEN | ATROPINE | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | ||
| N017106-002 | ATROPEN | ATROPINE | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | |
| N017106-003 | ATROPEN | ATROPINE | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | |
| N017106-004 | ATROPEN | ATROPINE | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | d8e5a09893c0… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ATROPEN Auto-Injector | ATROPINE | Meridian Medical Technologies LLC | e2d4307d-da8f-49f5-aac0-02355dd9ffb7 | 2022-09-15 | Warnings, Adverse reactions | 017106 NDA017106 11704-107 11704-105 11704-104 11704-101 11704-106 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 11704-101 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-101 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-101 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-101 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-101 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-101 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-101 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-104 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-104 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-104 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-104 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-104 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-104 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-104 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-104 | AtroPen Auto-Injector | Atropine sulfate | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-105 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-105 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-105 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-105 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-105 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-105 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-105 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-105 | AtroPen Auto-Injector | Atropine sulfate | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-106 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-106 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-106 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-106 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-106 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-106 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-106 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-106 | AtroPen Auto-Injector | Atropine sulfate | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-107 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-107 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-107 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-107 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-107 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies, Inc. | NDA | Current |
| 11704-107 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-107 | ATROPEN Auto-Injector | atropine | Meridian Medical Technologies LLC | NDA | Current |
| 11704-107 | AtroPen Auto-Injector | Atropine sulfate | Meridian Medical Technologies, Inc. | NDA | Current |